Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort

Bálint Anita and Rutka Mariann and Végh Zsuzsanna and Kürti Zsuzsanna and Gecse Krisztina Barbara and Lakatos László and Szepes Zoltán and Vincze Áron and Bor Renáta and Milassin Ágnes and Fábián Anna and Nagy Ferenc and Lakatos Péter László and Molnár Tamás and Farkas Klaudia: Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort.
EXPERT OPINION ON DRUG SAFETY, 16 (8). pp. 885-890. ISSN 1474-0338 (2017)

[thumbnail of 3225452_Balint_EODS_2017l_u.pdf]
Preview
Text
3225452_Balint_EODS_2017l_u.pdf - Published Version

Download (1MB) | Preview
Creators:
Bálint Anita MTMT
Rutka Mariann MTMT
Végh Zsuzsanna MTMT
Kürti Zsuzsanna MTMT
Gecse Krisztina Barbara MTMT
Lakatos László MTMT
Szepes Zoltán MTMT
Vincze Áron MTMT
Bor Renáta MTMT
Milassin Ágnes MTMT
Fábián Anna MTMT
Nagy Ferenc MTMT
Lakatos Péter László MTMT
Molnár Tamás MTMT
Farkas Klaudia MTMT
Item Type: Journal Article
Szerzők száma: 33
Journal or Publication Title: EXPERT OPINION ON DRUG SAFETY
Date: 2017
Volume: 16
Number: 8
Page Range: pp. 885-890
ISSN: 1474-0338
Faculty/Unit: Faculty of Medicine
Institution: University of Szeged (2000-)
Language: English
MTMT rekordazonosító: 3225452
DOI azonosító: https://doi.org/10.1080/14740338.2017.1323330
Date Deposited: 2017. Sep. 29. 12:10
Last Modified: 2019. Oct. 25. 11:32
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12010
Web of Science® Times Cited: 20 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year